汕头市妇女HPV-52感染与宫颈鳞状上皮病变的关系

doi:10.3969/j.issn.1004-616x.2020.04.010

癌变·畸变·突变 ›› 2020, Vol. 32 ›› Issue (4): 304-308.doi: 10.3969/j.issn.1004-616x.2020.04.010

汕头市妇女HPV-52感染与宫颈鳞状上皮病变的关系

王媛媛¹, 陈依超², 郑洁¹, 彭燕燕³, 王少洪¹

1. 汕头市中心医院病理科, 广东汕头 515041;
2. 汕头市中心医院临床医学研究中心, 广东汕头 515041;
3. 汕头市中心医院检验科, 广东汕头 515041

收稿日期:2020-01-08 修回日期:2020-05-19 出版日期:2020-07-31 发布日期:2020-08-01
作者简介:王媛媛,E-mail:315075516@qq.com
基金资助:
2018年汕头市中心医院科研培育计划优先资助项目（2018第56号）

Risk analysis of HPV-52 infection and cervical squamous epithelial lesions in Shantou, China

WANG Yuanyuan¹, CHEN Yichao², ZHENG Jie¹, PENG Yanyan³, WANG Shaohong¹

1. Department of Pathology, Shantou Central Hospital, Shantou 515041;
2. Department of Clinical Research Center, Shantou Central Hospital, Shantou 515041;
3. Department of Laboratory Medicine, Shantou Central Hospital, Shantou 515041, Guangdong, China

Received:2020-01-08 Revised:2020-05-19 Online:2020-07-31 Published:2020-08-01

摘要/Abstract

摘要： 目的： 探讨汕头市妇女感染人乳头状瘤病毒（HPV）的主要亚型，及其在宫颈鳞状上皮病变中的致病特点及风险分析。方法： 收集2015~2018年在汕头市中心医院同时进行HPV分型检测和薄层液基细胞学（LCT）检查的病例37 700例，及其中3 924例进行宫颈活检的病例。HPV分型检测采用医用核酸分子快速杂交基因分型试剂盒，包含15种高危HPV，即HPV-16、-18、-31、-33、-35、-39、-45、-5l、-52、-53、-56、-58、-59、-66和-68；6种低危型HPV，即HPV-6、-11、-42、-43、-44、CP8304。细胞学检查按照伯塞斯达系统（TBS）分级（2014版）标准进行分类，分为未见上皮内病变或恶性病变（NILM）、非典型鳞状细胞-意义不明确（ASC-US）、低级别鳞状上皮内病变（LSIL）、非典型鳞状细胞-不排除高级别鳞状上皮内病变（ASC-H）、高级别鳞状上皮内病变（HSIL）和鳞状细胞癌（SCC）。使用SPSS 19.0软件建立数据库，计数资料率的比较采用频数分布进行统计，风险评估采用卡方检验2×2列表。结果： 37 700位LCT检查病例中HPV-52总感染率为3.55%（1 338/37 700），HPV-52单一感染882例，HPV-52多重感染（指两种及以上HPV亚型感染）456例，其中包含两重感染313例，三重及以上感染143例，HPV-52多重感染最常见的3种亚型分别是HPV-58/52（12.46%，39/313）、HPV-53/52（11.18%，35/313）、HPV-16/52（11.18%，35/313）。HPV-52多重感染患者LCT筛查结果出现ASC-US及以上病变尤其是HSIL中，最多见型别为HPV-16/52。宫颈活检结果风险分析显示，与HPV-52单一感染比较，HPV-52/16多重感染患HSIL/SCC风险增加（P < 0.01，OR=8.27），并且增加HSIL发展到SCC的发病风险（P=0.01，OR=12.65）。与包含HPV-52但不包含HPV-16的多重感染比较，HPV-52/16多重感染增加患HSIL或者SCC风险（P < 0.01，OR=3.36），并且增加HSIL发展为SCC的风险（P=0.03，OR=1.29）。结论： HPV-52是汕头市妇女最常见的HPV感染宫颈亚型，但患者主要发生HSIL病变，当合并HPV-16感染时增加癌前病变及癌变风险。

关键词: 人乳头状瘤病毒, 宫颈癌, 多重感染, 分型

Abstract: OBJECTIVE: To explore pathogenic characteristics and risk of human papillomavirus-52 (HPV-52) infection in cervical squamous cell lesions in Shantou,China. METHODS: 37 700 cases of HPV typing and thin-layer liquid-based cytology (LCT),and 3 924 cases of cervical biopsy were collected in the Shantou Central Hospital from 2015 to 2018. HPV was detected by using the medical nucleic acid molecule rapid hybridization genotype kit which contained 15 high-risk HPV (HPV-16,-18,-31,-33,-35,-39, -45,-51,-52,-53,-56,-58,-59,-66,and -68) and 6 low-risk HPV (HPV-6,-11,-42,-43,-44, CP8304). Cytology examination was classified according to the TBS (the Bethesda system) classification standard (2014 version),and was divided into negative for intraepithelial lesion or malignancy (NILM),atypical squamous cells of undetermined significance (ASC-US), low-grade squamous intraepithelial lesion (LSIL), atypical squamous cells without exclusion of HSIL (ASC-H),high grade squamous intraepithelial lesion(HSIL) and squamous cell carcinoma (SCC). The database was established by SPSS 19.0. The rate comparison of the counted data was performed by using frequency distribution. The risk assessment was performed by using a chi-square test 2×2 list. RESULTS: The total infection rate of HPV-52 in 37 700 patients was 3.55% (1 338/37 700). There were 882 cases of HPV-52 single infection and 456 cases of HPV-52 multiple infection, including 313 cases of double infection and 143 cases of triple and above.The three most common genotype of HPV-52 multiple infection were HPV-58/52 (12.46%,39/313),HPV-53/52 (11.18%,35/313),HPV-16/52 (11.18%,35/313). The most common genotype was HPV-16/52 in ASC-US and above lesions,especially in HSIL. Risk analysis of cervical biopsy showed that HPV-52/16 increased the risk of HSIL/SCC,compared with HPV-52 single infection (P < 0.01,OR=8.27),and increased the risk from HSIL to SCC (P=0.01,OR=12.65). Multiple infections of HPV-52/16 increased the risk from HSIL to SCC,compared with multiple infections that included HPV-52 but not HPV-16 (P < 0.01,OR=3.36),and increased the risk from HSIL to SCC (P=0.03, OR=1.29). CONCLUSION: HPV-52 was the most common genotype in Shantou area but the patients suffered mainly HSIL lesions. On the other hand, infection with HPV-16 increased the risk of precancerous and cancerous lesions.

Key words: human papilloma virus, cervical cancer, multiple infection, genotype

中图分类号:

R737.33

王媛媛, 陈依超, 郑洁, 彭燕燕, 王少洪. 汕头市妇女HPV-52感染与宫颈鳞状上皮病变的关系[J]. 癌变·畸变·突变, 2020, 32(4): 304-308.

WANG Yuanyuan, CHEN Yichao, ZHENG Jie, PENG Yanyan, WANG Shaohong. Risk analysis of HPV-52 infection and cervical squamous epithelial lesions in Shantou, China[J]. Carcinogenesis, Teratogenesis & Mutagenesis, 2020, 32(4): 304-308.

参考文献

[1] BRAY F, FERLAY J, SOERJOMATARAM I, et al. Global cancer statistics 2018:GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J]. CA Cancer J Clin, 2018, 68(6):394-424.
[2] CHEN W Q, ZHENG R S, BAADE P D, et al. Cancer statistics in China, 2015[J]. CA Cancer J Clin, 2016, 66(2):115-132.
[3] KOLIOPOULOS G, NYAGA V N, SANTESSO N, et al. Cytology versus HPV testing for cervical cancer screening in the general population[J]. Cochrane Database Syst Rev, 2017, 8(8):CD008587.
[4] HOFFMAN S R, LE T, LOCKHART A, et al. Patterns of persistent HPV infection after treatment for cervical intraepithelial neoplasia (CIN):A systematic review[J]. Int J Cancer, 2017, 141(1):8-23.
[5] WANG Y Y, WANG S H, SHEN J H, et al. Genotype distribution of human papillomavirus among women with cervical cytological abnormalities or invasive squamous cell carcinoma in a high-incidence area of esophageal carcinoma in China[J]. Biomed Res Int, 2016, 2016:1256384.
[6] LI K M, LI Q L, SONG L, et al. The distribution and prevalence of human papillomavirus in women in mainland China[J]. Cancer, 2019, 125(7):1030-1037.
[7] WANG R, GUO X L, WISMAN G B, et al. Nationwide prevalence of human papillomavirus infection and viral genotype distribution in 37 cities in China[J]. BMC Infect Dis, 2015, 15:257.
[8] NAH E H, CHO S, KIM S, et al. Human papillomavirus genotype distribution among 18, 815 women in 13 Korean cities and relationship with cervical cytology findings[J]. Ann Lab Med, 2017, 37(5):426-433.
[9] JING L P, ZHONG X M, HUANG W H, et al. HPV genotypes and associated cervical cytological abnormalities in women from the Pearl River Delta region of Guangdong Province, China:a cross-sectional study[J]. BMC Infect Dis, 2014, 14:388.
[10] 冯淑燕, 冯淑玲. 1026例育龄妇女HPV感染情况调查及分析[J]. 中国妇幼保健, 2011, 26(9):1374-1377.
[11] 林亚珍, 唐忠辉, 黄仲庆, 等. 漳州地区HPV感染的基因型分布特点与宫颈病变的关系[J]. 山西医科大学学报, 2014, 45(12):1147-1150.
[12] BRUNI L, DIAZ M, FERRER E, et al. Cervical human papillomavirus prevalence in 5 continents:meta-analysis of 1 million women with normal cytological findings[J]. J Infect Dis, 2010, 202(12):1789-1799.
[13] SO K A, LEE I H, LEE K H, et al. Human papillomavirus genotype-specific risk in cervical carcinogenesis[J]. J Gynecol Oncol, 2019, 30(4):52.

[1]	王晓舟, 李洪石, 于溪, 魏宁, 王梓瑛, 赫丽杰. 青藤碱对HPV阳性宫颈癌SiHa细胞增殖和侵袭的影响[J]. 癌变·畸变·突变, 2021, 33(6): 442-445.
[2]	方磊, 杨涛, 盛磊, 木塔力甫·艾买提, 齐鑫鑫, 艾尼娃尔·艾克木, 伊力亚尔·尼加提. 黑种草子总皂苷对人宫颈癌SiHa细胞生物学行为的影响[J]. 癌变·畸变·突变, 2021, 33(2): 143-148,152.
[3]	兰莉, 陈海丽, 徐蕾. RBMS3-AS3对宫颈癌细胞增殖、凋亡和侵袭的影响及作用机制[J]. 癌变·畸变·突变, 2020, 32(6): 438-443.
[4]	盛磊, 武贵臻, 热娜古丽·热依木, 艾尼娃尔·艾克木. 新疆黑种草子总黄酮体外抗宫颈癌活性研究[J]. 癌变·畸变·突变, 2019, 31(5): 385-391.
[5]	余明辰, 吴楠, 孙冬琳, 金焰. 胶质母细胞瘤分子标志物的研究进展[J]. 癌变·畸变·突变, 2019, 31(5): 412-416.
[6]	徐苗, 张天一, 田菲菲. PD-1/PD-L1信号通路抑制剂在宫颈癌治疗中的研究进展[J]. 癌变·畸变·突变, 2019, 31(5): 417-420.
[7]	马月, 郑雨虹, 赵超, 刘冉, 浦跃朴, 尹立红. HPV联合MNNG对Het-1A细胞恶性转化的影响[J]. 癌变·畸变·突变, 2018, 30(6): 422-429,434.
[8]	郝轶, 袁建林, 肖悦, 李卉, 郭霞. 3种不同的HPV型别宫颈癌细胞株分泌蛋白非标记定量技术分析[J]. 癌变·畸变·突变, 2018, 30(5): 354-358,364.
[9]	迪拉热·力迪甫, 木塔力甫·艾买提, 盛磊, 古扎力努尔买提沙, 艾尔肯·肉孜比拉力, ABULIZI Abudula. HPV16编码蛋白与宫颈癌细胞内CALCA和TFPI-2表达的关系[J]. 癌变·畸变·突变, 2017, 29(6): 431-436.
[10]	宋淑芳, 常海平, 杨彩容, 赵荣伟, 张龙, 任杰, 郑健. 慢病毒介导的TPX2基因沉默对人宫颈癌HeLa细胞系增殖、迁移和细胞周期的影响及机制[J]. 癌变·畸变·突变, 2017, 29(5): 329-334,339.
[11]	刘好, 赵滢滢, 金平, 许改霞, 郭宇然, 张可, 王晓梅, 张蕾. 组蛋白去乙酰化酶抑制剂联合紫杉醇抑制宫颈癌细胞增殖的体外实验[J]. 癌变·畸变·突变, 2017, 29(5): 335-339.
[12]	丁立新, 赵现哲, 姜晓燕, 丁库克. 宫颈癌辐射敏感性相关基因的研究进展[J]. 癌变·畸变·突变, 2017, 29(5): 394-396,401.
[13]	沈伶, 许丽璇, 李小平, 胡桂英, 麦碧, 纪璇, 粟丽. 粤东地区妇女人乳头瘤病毒感染情况和亚型分布及其与宫颈癌的关系[J]. 癌变·畸变·突变, 2017, 29(3): 226-229.
[14]	刘平. 长链非编码RNA XIST和miR-101-3p在子宫颈癌组织中的表达及关系[J]. 癌变·畸变·突变, 2017, 29(2): 121-124.
[15]	张雪杉, 缪芳, 曹晏宁, 张晓姝. 婆罗双树样基因2干扰对宫颈癌HeLa细胞增殖和凋亡的影响[J]. 癌变·畸变·突变, 2016, 28(5): 359-363,368.

汕头市妇女HPV-52感染与宫颈鳞状上皮病变的关系

Risk analysis of HPV-52 infection and cervical squamous epithelial lesions in Shantou, China

PDF

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 15

编辑推荐

Metrics

本文评价